ID

26498

Description

A phase III, double-blinded, randomized, multicenter, clinical study to assess the safety and immunogenicity of GSK Biologicals' Tdap 0.3 mg candidate vaccine when given as a booster dose to healthy school children and adolescents (9-13 years of age), previously vaccinated with a 5th consecutive dose of acellular pertussis-containing vaccine, in studies APV-118 or APV-120 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00263679

Mots-clés

Versions (1)
  1. 18/10/2017 18/10/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

18 octobre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

GSK Study ID 100406/004 Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster Visit 2

Anglais

GSK Study ID 100406/004 Visit 2

1 Formulaires  
Check for Study Continuation
Description

Check for Study Continuation

Alias
UMLS CUI-1
C0805733
UMLS CUI-2
C0008976
UMLS CUI-3
C0042210
Protocol
Description

Protocol

Type de données

integer

Alias
UMLS CUI [1]
C1507394
CRF
Description

Case Report File

Type de données

text

Alias
UMLS CUI [1]
C1516308
Visit
Description

Visit

Type de données

text

Alias
UMLS CUI [1]
C0545082
Date of visit
Description

Date of visit

Type de données

date

Alias
UMLS CUI [1]
C1320303
Subject number
Description

Subject number

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Did the subject come at visit 2?
Description

Did the subject come at visit 2?

Type de données

boolean

Alias
UMLS CUI [1,1]
C0545082
UMLS CUI [1,2]
C0805733
UMLS CUI [1,3]
C0008976
Why didn´t the subject return to visit 2?
Description

Why didn´t the subject return to visit 2?

Type de données

integer

Alias
UMLS CUI [1]
C2348568
Please specify SAE N°
Description

Serious adverse event

Type de données

integer

Alias
UMLS CUI [1]
C1519255
Please specify AE type
Description

Non-serious adverse event

Type de données

integer

Alias
UMLS CUI [1]
C1518404
Please specify AE N° (Unsol.):
Description

Non-serious adverse event, unsolicited

Type de données

integer

Alias
UMLS CUI [1]
C1518404
Please specify AE N° (Solicited)
Description

Non-serious adverse event, solicited

Type de données

integer

Alias
UMLS CUI [1]
C1518404
Other, please specify:
Description

Other events

Type de données

text

Alias
UMLS CUI [1]
C0441471
Who took the decision:
Description

Who took the decision

Type de données

integer

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0679006
Pre-vaccination assessment
Description

Pre-vaccination assessment

Alias
UMLS CUI-1
C0220825
UMLS CUI-2
C0042196
Length of the upper arm (non-dominant) to be injected:
Description

Please record the length of the upper arm (non-dominant). Clothing should be removed as to not interfere with the measurement. The upper arm length is defined as the distance between the acromion and the tip of the elbow.

Type de données

integer

Unités de mesure
  • mm
Alias
UMLS CUI [1,1]
C0426866
UMLS CUI [1,2]
C0446516
mm
Circumference of the mid upper arm (non-dominant) to be injected:
Description

The measurement will be performed at the mid-point of the upper arm (at mid distance between the acromion and the tip of the elbow), while the arm is held parallel to the trunk and the elbow is flexed in front at 90o (as if the subject were carrying a tray). Clothing (e.g., shirt, sweater, blouse) should be removed so as not to interfere with the measurements. The deltoid muscle should not be contracted during the measurement. The mid-point of the upper arm will be marked by study personnel at the time of r measurement and will be used as reference for further measurements done by the subject or subject's parents / guardian during the follow-up period.

Type de données

integer

Unités de mesure
  • mm
Alias
UMLS CUI [1]
C0562351
mm
Temperature
Description

Temperature

Type de données

float

Unités de mesure
  • degrees celsius
Alias
UMLS CUI [1]
C0005903
degrees celsius
Temperature, measurement site
Description

Temperature, measurement site

Type de données

integer

Alias
UMLS CUI [1]
C0489453
Laboratory tests
Description

Laboratory tests

Alias
UMLS CUI-1
C0022885
Blood sample
Description

Blood sample

Alias
UMLS CUI-1
C0005834
Has a blood sample been taken?
Description

Has a blood sample been taken?

Type de données

boolean

Alias
UMLS CUI [1]
C0005834
Date blood sample taken
Description

Please complete only if different from visit date:

Type de données

date

Alias
UMLS CUI [1,1]
C0005834
UMLS CUI [1,2]
C0011008
URINE SAMPLE (Pregnancy test – HCG)
Description

URINE SAMPLE (Pregnancy test – HCG)

Alias
UMLS CUI-1
C0200354
Has a urine sample been taken?
Description

Has a urine sample been taken?

Type de données

integer

Alias
UMLS CUI [1]
C0200354
Date urine sample taken
Description

Please complete only if different from visit date

Type de données

date

Alias
UMLS CUI [1,1]
C0200354
UMLS CUI [1,2]
C0011008
Pregnancy test result
Description

Pregnancy test result

Type de données

integer

Alias
UMLS CUI [1]
C0032976
Vaccine adminstration
Description

Vaccine adminstration

Alias
UMLS CUI-1
C2368628
Please complete only if different from visit date:
Description

Date of vaccine administration

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C2368628
Vaccine administration
Description

(only one box must be ticked by vaccine) Subjects who received dTpa 0.3 mg at Visit 1 will receive Havrix® at Visit 2 and subjects who receive Havrix® at Visit 1 will receive dTpa 0.3 mg at Visit 2.

Type de données

integer

Alias
UMLS CUI [1]
C2368628
Side / site route
Description

Non-dominant, upper deltoid, i.m.

Type de données

integer

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C0042210
Has the study vaccine been administered according to the protocol?
Description

Has the study vaccine been administered according to the protocol?

Type de données

boolean

Alias
UMLS CUI [1,1]
C2368628
UMLS CUI [1,2]
C2599718
Arm:
Description

Handedness

Type de données

integer

Alias
UMLS CUI [1]
C0023114
Site:
Description

Anatomic site

Type de données

integer

Alias
UMLS CUI [1,1]
C2368628
UMLS CUI [1,2]
C1515974
Route:
Description

Drug administration route

Type de données

integer

Alias
UMLS CUI [1]
C0013153
Comments:
Description

Comments

Type de données

text

Alias
UMLS CUI [1]
C0947611
Why not administered?
Description

Why not administered?

Alias
UMLS CUI-1
C0042210
UMLS CUI-2
C1548562
Category for non administration:
Description

Category for non administration

Type de données

integer

Alias
UMLS CUI [1,1]
C1533734
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C1272696
Please specify SAE N°
Description

Serious Adverse Event

Type de données

integer

Alias
UMLS CUI [1]
C1519255
Please specify AE type
Description

Non-serious adverse event

Type de données

integer

Alias
UMLS CUI [1]
C1518404
Please specify AE N° (Unsol.):
Description

Non-serious adverse event, unsolicited

Type de données

integer

Alias
UMLS CUI [1]
C1518404
Please specify AE N° (Solicited)
Description

Non-serious adverse event, solicited

Type de données

integer

Alias
UMLS CUI [1]
C1518404
Other, please specify:
Description

(e.g.: consent withdrawal, Protocol violation, …)

Type de données

text

Alias
UMLS CUI [1]
C0877248
Who took the decision:
Description

Who took the decision

Type de données

integer

Alias
UMLS CUI [1,1]
C0679006
UMLS CUI [1,2]
C0042210
UMLS CUI [1,3]
C1548562
Adverse events - Post - vaccination oberservation
Description

Adverse events - Post - vaccination oberservation

Alias
UMLS CUI-1
C0042196
UMLS CUI-2
C0700325
UMLS CUI-3
C0877248
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
Description

Serious or non-serious unsolicited adverse events after vaccination

Type de données

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0042196
UMLS CUI [2,1]
C1518404
UMLS CUI [2,2]
C0042196
Retour au début de la page

Similar models

GSK Study ID 100406/004 Visit 2

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Check for Study Continuation
C0805733 (UMLS CUI-1)
C0008976 (UMLS CUI-2)
C0042210 (UMLS CUI-3)
Protocol
Item
Protocol
integer
C1507394 (UMLS CUI [1])
Case Report File
Item
CRF
text
C1516308 (UMLS CUI [1])
Visit
Item
Visit
text
C0545082 (UMLS CUI [1])
Date of visit
Item
Date of visit
date
C1320303 (UMLS CUI [1])
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Did the subject come at visit 2?
Item
Did the subject come at visit 2?
boolean
C0545082 (UMLS CUI [1,1])
C0805733 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Item
Why didn´t the subject return to visit 2?
integer
C2348568 (UMLS CUI [1])
Why didn´t the subject return to visit 2?
Code List
Why didn´t the subject return to visit 2?
CL Item
Serious adverse event (complete the Serious Adverse Event form) (1)
CL Item
Non-Serious adverse event (complete the Non-serious Adverse Event page) (2)
CL Item
Other (3)
Serious adverse event
Item
Please specify SAE N°
integer
C1519255 (UMLS CUI [1])
Item
Please specify AE type
integer
C1518404 (UMLS CUI [1])
Non-serious adverse event
Code List
Please specify AE type
CL Item
Unsolicited (1)
CL Item
Solicited (2)
Non-serious adverse event, unsolicited
Item
Please specify AE N° (Unsol.):
integer
C1518404 (UMLS CUI [1])
Non-serious adverse event, solicited
Item
Please specify AE N° (Solicited)
integer
C1518404 (UMLS CUI [1])
Other events
Item
Other, please specify:
text
C0441471 (UMLS CUI [1])
Item
Who took the decision:
integer
C2348568 (UMLS CUI [1,1])
C0679006 (UMLS CUI [1,2])
Who took the decision
Code List
Who took the decision:
CL Item
Investigator (1)
CL Item
Parents/Guardians (2)
Item Group
Pre-vaccination assessment
C0220825 (UMLS CUI-1)
C0042196 (UMLS CUI-2)
Baseline measurement of the length of upper arm to be injected
Item
Length of the upper arm (non-dominant) to be injected:
integer
C0426866 (UMLS CUI [1,1])
C0446516 (UMLS CUI [1,2])
Baseline measurement of mid upper arm circumference
Item
Circumference of the mid upper arm (non-dominant) to be injected:
integer
C0562351 (UMLS CUI [1])
Temperature
Item
Temperature
float
C0005903 (UMLS CUI [1])
Item
Temperature, measurement site
integer
C0489453 (UMLS CUI [1])
Temperature, measurement site
Code List
Temperature, measurement site
CL Item
Axillary (preferred) (1)
CL Item
Oral (2)
Item Group
Laboratory tests
C0022885 (UMLS CUI-1)
Item Group
Blood sample
C0005834 (UMLS CUI-1)
Has a blood sample been taken?
Item
Has a blood sample been taken?
boolean
C0005834 (UMLS CUI [1])
Date blood sample taken
Item
Date blood sample taken
date
C0005834 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
URINE SAMPLE (Pregnancy test – HCG)
C0200354 (UMLS CUI-1)
Item
Has a urine sample been taken?
integer
C0200354 (UMLS CUI [1])
Has a urine sample been taken?
Code List
Has a urine sample been taken?
CL Item
Yes (1)
CL Item
No (2)
CL Item
NA (not of childbearing potential or male) (3)
Date urine sample taken
Item
Date urine sample taken
date
C0200354 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Pregnancy test result
integer
C0032976 (UMLS CUI [1])
Pregnancy test result
Code List
Pregnancy test result
CL Item
Negative (1)
CL Item
Positive (2)
Item Group
Vaccine adminstration
C2368628 (UMLS CUI-1)
Date of vaccine administration
Item
Please complete only if different from visit date:
date
C0011008 (UMLS CUI [1,1])
C2368628 (UMLS CUI [1,2])
Item
Vaccine administration
integer
C2368628 (UMLS CUI [1])
Vaccine administration
Code List
Vaccine administration
CL Item
Crossover vaccine (1)
CL Item
Replacement vial (2)
CL Item
Wrong vial number (3)
CL Item
Not administered (4)
Item
Side / site route
integer
C0013153 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Side / site route
Code List
Side / site route
CL Item
Left (1)
CL Item
Right (2)
Has the study vaccine been administered according to the protocol?
Item
Has the study vaccine been administered according to the protocol?
boolean
C2368628 (UMLS CUI [1,1])
C2599718 (UMLS CUI [1,2])
Item
Arm:
integer
C0023114 (UMLS CUI [1])
Handedness
Code List
Arm:
CL Item
Dominant (1)
CL Item
Non dominant (2)
CL Item
NA (3)
Item
Site:
integer
C2368628 (UMLS CUI [1,1])
C1515974 (UMLS CUI [1,2])
Anatomic Site
Code List
Site:
CL Item
Deltoid (1)
CL Item
Thigh (2)
CL Item
Buttock (3)
Item
Route:
integer
C0013153 (UMLS CUI [1])
Drug administration route
Code List
Route:
CL Item
I.m. (1)
CL Item
S.c. (2)
Comments
Item
Comments:
text
C0947611 (UMLS CUI [1])
Item Group
Why not administered?
C0042210 (UMLS CUI-1)
C1548562 (UMLS CUI-2)
Item
Category for non administration:
integer
C1533734 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C1272696 (UMLS CUI [1,3])
Category for non administration
Code List
Category for non administration:
CL Item
Serious adverse event (complete the Serious Adverse Event form) (1)
CL Item
Non-Serious adverse event (complete the Non-serious Adverse Event page) (2)
CL Item
Other (3)
Serious Adverse Event
Item
Please specify SAE N°
integer
C1519255 (UMLS CUI [1])
Item
Please specify AE type
integer
C1518404 (UMLS CUI [1])
Non-serious adverse event
Code List
Please specify AE type
CL Item
Unsolicited (1)
CL Item
Solicited (2)
Non-serious adverse event, unsolicited
Item
Please specify AE N° (Unsol.):
integer
C1518404 (UMLS CUI [1])
Non-serious adverse event, solicited
Item
Please specify AE N° (Solicited)
integer
C1518404 (UMLS CUI [1])
Other adverse event
Item
Other, please specify:
text
C0877248 (UMLS CUI [1])
Item
Who took the decision:
integer
C0679006 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
C1548562 (UMLS CUI [1,3])
Who took the decision
Code List
Who took the decision:
CL Item
Investigator (1)
CL Item
Parents/Guardians (2)
Item Group
Adverse events - Post - vaccination oberservation
C0042196 (UMLS CUI-1)
C0700325 (UMLS CUI-2)
C0877248 (UMLS CUI-3)
Item
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
integer
C1519255 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
C1518404 (UMLS CUI [2,1])
C0042196 (UMLS CUI [2,2])
Serious or non-serious unsolicited adverse events after vaccination
Code List
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
CL Item
Information not retrievable (1)
CL Item
No vaccine administered (2)
CL Item
No (3)
CL Item
Yes, fill in the non-serious adverse event pages or serious adverse event form. (4)
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial